Two sides of the same coin: stem cells in cancer and regenerative medicine

FASEB J. 2014 Jul;28(7):2748-61. doi: 10.1096/fj.13-244640. Epub 2014 Mar 27.

Abstract

Multipotent stromal cells (MSCs) derived from bone marrow, adipose tissue, cord blood, and other origins have recently received much attention as potential therapeutic agents with beneficial immunomodulatory and regenerative properties. In their native tissue environment, however, such cells also appear to have essential functions in building and supporting tumor microenvironments, providing metastatic niches, and maintaining cancer hallmarks. Here, we consider the varied roles of these tissue-resident stroma-associated cells, synthesize recent and emerging discoveries, and discuss the role, potential, and clinical applications of MSCs in cancer and regenerative medicine.-Ilmer, M., Vykoukal, J., Recio Boiles, A., Coleman, M., Alt, E. Two sides of the same coin: stem cells in cancer and regenerative medicine.

Keywords: Warburg; epithelial-mesenchymal transition; exosomes; mesenchymal stromal cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Humans
  • Neoplasms / etiology*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Regenerative Medicine / methods*
  • Stem Cells / pathology*
  • Stem Cells / physiology*